Back to DE Deerfield Management Company, L.P.
CYTK
Showing 1 of 14 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in Cytokinetics, Incorporated
No. Deerfield Management exited its CYTK (Cytokinetics) position in Q4 2024. Its Q3 2024 13F listed 12,884 shares worth $680,275. Deerfield Management first reported CYTK in Q4 2020 and held it in 12 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC